We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

49 hedge funds and large institutions have $20.5M invested in NantHealth, Inc in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 8

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

10% more capital invested

Capital invested by funds: $18.6M → $20.5M (+$1.91M)

2% more funds holding

Funds holding: 4849 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $81K

Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
22
Reduced
8
Closed
5
Calls
Puts
$81K
Net Calls
-$81K
Net Calls Change
-$73K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$7.74M +$639K +12,900 +9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.09M -$20.3K -410 -1%
Blackstone Inc
3
Blackstone Inc
New York
$1.98M
Morgan Stanley
4
Morgan Stanley
New York
$1.7M +$401K +8,111 +31%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.19M +$108K +2,182 +10%
Northern Trust
6
Northern Trust
Illinois
$771K +$103K +2,090 +16%
WCM
7
Wildcat Capital Management
New York
$663K
State Street
8
State Street
Massachusetts
$657K -$2.67K -54 -0.4%
AG
9
Advisor Group
Arizona
$581K +$11.8K +238 +2%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$398K +$117K +2,363 +42%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$244K +$36K +727 +17%
Deutsche Bank
12
Deutsche Bank
Germany
$228K +$106K +2,151 +88%
Goldman Sachs
13
Goldman Sachs
New York
$226K -$7.47K -151 -3%
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$215K +$159K +3,209 +287%
DekaBank Deutsche Girozentrale
15
DekaBank Deutsche Girozentrale
Germany
$180K
ProShare Advisors
16
ProShare Advisors
Maryland
$160K -$12.5K -252 -7%
TCIM
17
TIAA CREF Investment Management
New York
$139K -$5.05K -102 -4%
PCM
18
Palisade Capital Management
New Jersey
$126K +$125K +2,533 New
Citadel Advisors
19
Citadel Advisors
Florida
$121K +$63.1K +1,274 +110%
AllianceBernstein
20
AllianceBernstein
Tennessee
$113K +$2.67K +54 +2%
Renaissance Technologies
21
Renaissance Technologies
New York
$110K +$19.2K +387 +21%
TA
22
Teachers Advisors
New York
$105K
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$104K +$23.4K +473 +29%
Charles Schwab
24
Charles Schwab
California
$101K
PPA
25
Parametric Portfolio Associates
Washington
$99K +$15.7K +318 +19%

NH Hedge Fund Activity: Q2 2018 in Review

49 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q2 2018, worth a combined $20.5M — up 10% from $18.6M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NH positions and 5 closed out — a net gain of 1 holder — while 22 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $639K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $907K sold.

  • 49 institutional investors held NantHealth, Inc (NH) as of Q2 2018, up from 48 in Q1 2018.
  • Funds reported $20.5M of NantHealth, Inc stock for Q2 2018, up 10% quarter-over-quarter.
  • 6 funds opened new NantHealth, Inc positions in Q2 2018 and 5 closed out, a net change of +1 holder.
  • The largest NantHealth, Inc buyer in Q2 2018 was BlackRock, an estimated $639K added.
  • The largest NantHealth, Inc seller in Q2 2018 was Alyeska Investment Group, an estimated $907K sold.

Based on aggregated 13F filings for Q2 2018.